MoneyWorks4Me

The sales for the June 2025 quarter moved up 39.21% to Rs. 1114.79 millions as compared to Rs. 800.79 millions during the corresponding quarter last year.Good  Net Profit growth of 42.62% reported above the corresponding previous quarter figure of Rs. 83.67 millions to Rs. 119.33 millioins.Operating profit surged to 245.61 millions from the corresponding previous quarter of 176.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1114.79 800.79 39.21 1114.79 800.79 39.21 3701.97 3071.72 20.52
Other Income 3.76 2.78 35.25 3.76 2.78 35.25 19.20 18.30 4.92
PBIDT 245.61 176.35 39.27 245.61 176.35 39.27 823.64 684.63 20.30
Interest 27.60 24.78 11.38 27.60 24.78 11.38 98.78 103.87 -4.90
PBDT 218.01 151.57 43.83 218.01 151.57 43.83 724.86 509.77 42.19
Depreciation 47.60 40.19 18.44 47.60 40.19 18.44 182.58 195.11 -6.42
PBT 170.41 111.38 53.00 170.41 111.38 53.00 542.28 314.66 72.34
TAX 51.08 27.71 84.34 51.08 27.71 84.34 143.38 74.83 91.61
Deferred Tax 7.49 -0.32 -2440.63 7.49 -0.32 -2440.63 -15.89 -4.37 263.62
PAT 119.33 83.67 42.62 119.33 83.67 42.62 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.03 22.02 0.04 22.03 22.02 0.05 22.25 22.29 -0.18
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..